{"id":320031,"date":"2026-02-04T16:04:09","date_gmt":"2026-02-04T16:04:09","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/320031\/"},"modified":"2026-02-04T16:04:09","modified_gmt":"2026-02-04T16:04:09","slug":"ge-healthcare-forecasts-2026-profit-above-estimates-on-strong-demand-for-medical-devices","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/320031\/","title":{"rendered":"GE HealthCare forecasts 2026 profit above estimates on strong demand for medical devices"},"content":{"rendered":"\n<p class=\"yf-vbsvxt\">Feb 4 (Reuters) &#8211; GE HealthCare on Wednesday forecast annual profit above Wall Street estimates, betting on robust demand for its \u200bdiagnostic and imaging devices.<\/p>\n<p class=\"yf-vbsvxt\">Resilient demand for medical procedures, particularly from \u200colder Americans, has prompted hospitals to invest in diagnostic and medical devices over the past \u200ccouple of years. The company makes CT, X-ray and PET scanners as well as range of other devices.<\/p>\n<p class=\"yf-vbsvxt\">Revenue at GE HealthCare&#8217;s imaging devices unit \u2014 the largest of its four segments \u2014 rose 6.6% to $2.55 billion in the \u2060fourth quarter.<\/p>\n<p class=\"yf-vbsvxt\">Shares were up \u200cup 2.4% at $80.70 in premarket trading, after the company also beat fourth-quarter earnings estimates.<\/p>\n<p class=\"yf-vbsvxt\">The revenue growth was also \u200ddriven by strength in U.S. and European markets, it said.<\/p>\n<p class=\"yf-vbsvxt\">&#8220;This reflects healthy capital investment trends, commercial execution and demand for new products,&#8221; said CEO Peter Arduini.<\/p>\n<p class=\"yf-vbsvxt\">Its \u200bother three businesses are advanced visualization solutions, patient care solutions and \u200cpharmaceutical diagnostics.<\/p>\n<p class=\"yf-vbsvxt\">The company said it anticipates 2026 tariff impact to be lower than last year, based on current rates.<\/p>\n<p class=\"yf-vbsvxt\">GE HealthCare in October said it expected a $265 million, or 45-cents-per-share, impact in 2025 from U.S. President Donald Trump&#8217;s tariffs on copper, steel and aluminum derivatives.<\/p>\n<p class=\"yf-vbsvxt\">The medical device maker \u2060expects 2026 adjusted profit per share in \u200bthe range of $4.95 to $5.15, compared with \u200banalysts&#8217; estimates of $4.92 per share, according to data compiled by LSEG.<\/p>\n<p class=\"yf-vbsvxt\">The company also expects 2026 organic revenue growth of 3% \u200dto 4% year-over-year.<\/p>\n<p class=\"yf-vbsvxt\">On \u2060an adjusted basis, GE HealthCare earned a profit of $1.44 per share during the quarter ended December 31, compared with estimates of $1.40 \u2060per share.<\/p>\n<p class=\"yf-vbsvxt\">Total quarterly sales came in at $5.7 billion, up 7.1% from a year ago \u200cand higher than analysts&#8217; average estimate of $5.61 billion.<\/p>\n<p class=\"yf-vbsvxt\">(Reporting by Sneha \u200cS K; Editing by Sahal Muhammed)<\/p>\n","protected":false},"excerpt":{"rendered":"Feb 4 (Reuters) &#8211; GE HealthCare on Wednesday forecast annual profit above Wall Street estimates, betting on robust&hellip;\n","protected":false},"author":2,"featured_media":320032,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[275],"tags":[101616,18,38256,135,475,474,19,17,21723,39211,94495,14609,67018,90100],"class_list":{"0":"post-320031","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-healthcare","8":"tag-earnings-estimates","9":"tag-eire","10":"tag-ge-healthcare","11":"tag-health","12":"tag-health-care","13":"tag-healthcare","14":"tag-ie","15":"tag-ireland","16":"tag-medical-devices","17":"tag-medical-procedures","18":"tag-profit","19":"tag-revenue-growth","20":"tag-robust-demand","21":"tag-wall-street-estimates"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ie\/116013214248078125","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/320031","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=320031"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/320031\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/320032"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=320031"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=320031"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=320031"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}